A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
National Cancer Institute (NCI)
Labcorp Corporation of America Holdings, Inc
European Organisation for Research and Treatment of Cancer - EORTC